Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Cell ; 174(1): 143-155.e16, 2018 06 28.
Article in English | MEDLINE | ID: mdl-29779947

ABSTRACT

Neisseria meningitidis, a bacterium responsible for meningitis and septicemia, proliferates and eventually fills the lumen of blood capillaries with multicellular aggregates. The impact of this aggregation process and its specific properties are unknown. We first show that aggregative properties are necessary for efficient infection and study their underlying physical mechanisms. Micropipette aspiration and single-cell tracking unravel unique features of an atypical fluidized phase, with single-cell diffusion exceeding that of isolated cells. A quantitative description of the bacterial pair interactions combined with active matter physics-based modeling show that this behavior relies on type IV pili active dynamics that mediate alternating phases of bacteria fast mutual approach, contact, and release. These peculiar fluid properties proved necessary to adjust to the geometry of capillaries upon bacterial proliferation. Intermittent attractive forces thus generate a fluidized phase that allows for efficient colonization of the blood capillary network during infection.


Subject(s)
Bacterial Adhesion/physiology , Capillaries/microbiology , Fimbriae, Bacterial/physiology , Neisseria meningitidis/pathogenicity , Animals , Bacterial Load , Capillaries/pathology , Endothelium/metabolism , Endothelium/microbiology , Endothelium/pathology , Female , Fimbriae Proteins/metabolism , Human Umbilical Vein Endothelial Cells , Humans , Male , Mice , Mice, SCID , Microscopy, Confocal , Neisseria meningitidis/physiology , Skin Transplantation , Surface Tension , Time-Lapse Imaging , Transplantation, Heterologous
2.
J Autoimmun ; 75: 105-117, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27528513

ABSTRACT

As it has been established that demethylation of lysine 27 of histone H3 by the lysine-specific demethylase JMJD3 increases immune responses and thus elicits inflammation, we hypothesize that inhibition of JMJD3 may attenuate autoimmune disorders. We found that in vivo administration of GSK-J4, a selective inhibitor of JMJD3 and UTX, ameliorates the severity of experimental autoimmune encephalomyelitis (EAE). In vitro experiments revealed that the anti-inflammatory effect of GSK-J4 was exerted through an effect on dendritic cells (DCs), promoting a tolerogenic profile characterized by reduced expression of costimulatory molecules CD80/CD86, an increased expression of tolerogenic molecules CD103 and TGF-ß1, and reduced secretion of proinflammatory cytokines IL-6, IFN-γ, and TNF. Adoptive transfer of GSK-J4-treated DCs into EAE mice reduced the clinical manifestation of the disease and decreased the extent of inflammatory CD4+ T cells infiltrating the central nervous system. Notably, Treg generation, stability, and suppressive activity were all exacerbated by GSK-J4-treated DCs without affecting Th1 and Th17 cell production. Our data show that GSK-J4-mediated modulation of inflammation is achieved by a direct effect on DCs and that systemic treatment with GSK-J4 or adoptive transfer of GSK-J4-treated DCs ex vivo may be promising approaches for the treatment of inflammatory and autoimmune disorders.


Subject(s)
Benzazepines/pharmacology , Dendritic Cells/drug effects , Encephalomyelitis, Autoimmune, Experimental/prevention & control , Jumonji Domain-Containing Histone Demethylases/antagonists & inhibitors , Pyrimidines/pharmacology , Adoptive Transfer , Animals , Antigens, CD/immunology , Antigens, CD/metabolism , B7-1 Antigen/immunology , B7-1 Antigen/metabolism , B7-2 Antigen/immunology , B7-2 Antigen/metabolism , Blotting, Western , CD4-Positive T-Lymphocytes/immunology , Cytokines/genetics , Cytokines/immunology , Cytokines/metabolism , Dendritic Cells/immunology , Dendritic Cells/metabolism , Encephalomyelitis, Autoimmune, Experimental/genetics , Encephalomyelitis, Autoimmune, Experimental/immunology , Gene Expression/drug effects , Immune Tolerance/genetics , Immune Tolerance/immunology , Inflammation Mediators/immunology , Inflammation Mediators/metabolism , Integrin alpha Chains/immunology , Integrin alpha Chains/metabolism , Jumonji Domain-Containing Histone Demethylases/immunology , Jumonji Domain-Containing Histone Demethylases/metabolism , Mice, Inbred C57BL , Mice, Transgenic , Phenotype , Reverse Transcriptase Polymerase Chain Reaction , Transforming Growth Factor beta1/immunology , Transforming Growth Factor beta1/metabolism
3.
Immunology ; 139(1): 61-71, 2013 May.
Article in English | MEDLINE | ID: mdl-23278668

ABSTRACT

T helper type 17 (Th17) lymphocytes are found in high frequency in tumour-burdened animals and cancer patients. These lymphocytes, characterized by the production of interleukin-17 and other pro-inflammatory cytokines, have a well-defined role in the development of inflammatory and autoimmune pathologies; however, their function in tumour immunity is less clear. We explored possible opposing anti-tumour and tumour-promoting functions of Th17 cells by evaluating tumour growth and the ability to promote tumour infiltration of myeloid-derived suppressor cells (MDSC), regulatory T cells and CD4(+)  interferon-γ(+) cells in a retinoic acid-like orphan receptor γt (RORγt) -deficient mouse model. A reduced percentage of Th17 cells in the tumour microenvironment in RORγt-deficient mice led to enhanced tumour growth, that could be reverted by adoptive transfer of Th17 cells. Differences in tumour growth were not associated with changes in the accumulation or suppressive function of MDSC and regulatory T cells but were related to a decrease in the proportion of CD4(+) T cells in the tumour. Our results suggest that Th17 cells do not affect the recruitment of immunosuppressive populations but favour the recruitment of effector Th1 cells to the tumour, thereby promoting anti-tumour responses.


Subject(s)
Immune Tolerance , Neoplasms/immunology , Th1 Cells/immunology , Th17 Cells/immunology , Animals , Cell Line, Tumor , Mice , Mice, Mutant Strains , Neoplasms/genetics , Neoplasms/pathology , Nuclear Receptor Subfamily 1, Group F, Member 3/genetics , Nuclear Receptor Subfamily 1, Group F, Member 3/immunology , Th1 Cells/pathology , Th17 Cells/pathology
4.
Clin Dev Immunol ; 2013: 679804, 2013.
Article in English | MEDLINE | ID: mdl-23737814

ABSTRACT

Regulatory T cells are a specific subset of lymphocytes that suppress immune responses and play a crucial role in the maintenance of self-tolerance. They can be generated in the thymus as well as in the periphery through differentiation of naïve CD4(+) T cells. The forkhead box P3 transcription factor (Foxp3) is a crucial molecule regulating the generation and function of Tregs. Here we show that the foxp3 gene promoter becomes hyperacetylated in in vitro differentiated Tregs compared to naïve CD4(+) T cells. We also show that the histone deacetylase inhibitor TSA stimulated the in vitro differentiation of naïve CD4(+) T cells into Tregs and that this induction was accompanied by a global increase in histone H3 acetylation. Importantly, we also demonstrated that Tregs generated in the presence of TSA have phenotypical and functional differences from the Tregs generated in the absence of TSA. Thus, TSA-generated Tregs showed increased suppressive activities, which could potentially be explained by a mechanism involving the ectonucleotidases CD39 and CD73. Our data show that TSA could potentially be used to enhance the differentiation and suppressive function of CD4(+)Foxp3(+) Treg cells.


Subject(s)
CD4-Positive T-Lymphocytes/drug effects , Histone Deacetylase Inhibitors/pharmacology , Hydroxamic Acids/pharmacology , Immune Tolerance , T-Lymphocytes, Regulatory/drug effects , 5'-Nucleotidase/genetics , 5'-Nucleotidase/immunology , Acetylation , Animals , Antigens, CD/genetics , Antigens, CD/immunology , Apyrase/genetics , Apyrase/immunology , CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , Cell Differentiation/drug effects , Cytokines/biosynthesis , Cytokines/immunology , Forkhead Transcription Factors/genetics , Forkhead Transcription Factors/immunology , Gene Expression Regulation , Genes, Reporter , Green Fluorescent Proteins , Histones/genetics , Histones/immunology , Histones/metabolism , Mice , Mice, Transgenic , Promoter Regions, Genetic , T-Lymphocytes, Regulatory/cytology , T-Lymphocytes, Regulatory/immunology
5.
Nat Commun ; 14(1): 3034, 2023 05 26.
Article in English | MEDLINE | ID: mdl-37236926

ABSTRACT

Renal medullary carcinoma (RMC) is an aggressive tumour driven by bi-allelic loss of SMARCB1 and tightly associated with sickle cell trait. However, the cell-of-origin and oncogenic mechanism remain poorly understood. Using single-cell sequencing of human RMC, we defined transformation of thick ascending limb (TAL) cells into an epithelial-mesenchymal gradient of RMC cells associated with loss of renal epithelial transcription factors TFCP2L1, HOXB9 and MITF and gain of MYC and NFE2L2-associated oncogenic and ferroptosis resistance programs. We describe the molecular basis for this transcriptional switch that is reversed by SMARCB1 re-expression repressing the oncogenic and ferroptosis resistance programs leading to ferroptotic cell death. Ferroptosis resistance links TAL cell survival with the high extracellular medullar iron concentrations associated with sickle cell trait, an environment propitious to the mutagenic events associated with RMC development. This unique environment may explain why RMC is the only SMARCB1-deficient tumour arising from epithelial cells, differentiating RMC from rhabdoid tumours arising from neural crest cells.


Subject(s)
Carcinoma, Medullary , Carcinoma, Renal Cell , Ferroptosis , Kidney Neoplasms , Sickle Cell Trait , Humans , Kidney Neoplasms/pathology , Carcinoma, Medullary/metabolism , Carcinoma, Renal Cell/pathology , SMARCB1 Protein/genetics , SMARCB1 Protein/metabolism , Repressor Proteins , Homeodomain Proteins
6.
Nat Commun ; 14(1): 6669, 2023 10 20.
Article in English | MEDLINE | ID: mdl-37863903

ABSTRACT

Atypical teratoid rhabdoid tumors (ATRT) are divided into MYC, TYR and SHH subgroups, suggesting diverse lineages of origin. Here, we investigate the imaging of human ATRT at diagnosis and the precise anatomic origin of brain tumors in the Rosa26-CreERT2::Smarcb1flox/flox model. This cross-species analysis points to an extra-cerebral origin for MYC tumors. Additionally, we clearly distinguish SHH ATRT emerging from the cerebellar anterior lobe (CAL) from those emerging from the basal ganglia (BG) and intra-ventricular (IV) regions. Molecular characteristics point to the midbrain-hindbrain boundary as the origin of CAL SHH ATRT, and to the ganglionic eminence as the origin of BG/IV SHH ATRT. Single-cell RNA sequencing on SHH ATRT supports these hypotheses. Trajectory analyses suggest that SMARCB1 loss induces a de-differentiation process mediated by repressors of the neuronal program such as REST, ID and the NOTCH pathway.


Subject(s)
Brain Neoplasms , Rhabdoid Tumor , Teratoma , Humans , Rhabdoid Tumor/genetics , Multiomics , SMARCB1 Protein/genetics , Transcription Factors/genetics , Brain Neoplasms/genetics , Diagnostic Imaging , Teratoma/pathology , Hedgehog Proteins/genetics
7.
Nat Commun ; 12(1): 4547, 2021 07 27.
Article in English | MEDLINE | ID: mdl-34315900

ABSTRACT

The human pathogen Neisseria meningitidis can cause meningitis and fatal systemic disease. The bacteria colonize blood vessels and rapidly cause vascular damage, despite a neutrophil-rich inflammatory infiltrate. Here, we use a humanized mouse model to show that vascular colonization leads to the recruitment of neutrophils, which partially reduce bacterial burden and vascular damage. This partial effect is due to the ability of bacteria to colonize capillaries, venules and arterioles, as observed in human samples. In venules, potent neutrophil recruitment allows efficient bacterial phagocytosis. In contrast, in infected capillaries and arterioles, adhesion molecules such as E-Selectin are not expressed on the endothelium, and intravascular neutrophil recruitment is minimal. Our results indicate that the colonization of capillaries and arterioles by N. meningitidis creates an intravascular niche that precludes the action of neutrophils, resulting in immune escape and progression of the infection.


Subject(s)
Arterioles/microbiology , Dermis/blood supply , Neisseria meningitidis/growth & development , Neutrophils/microbiology , Adult , Animals , Arterioles/pathology , Bacterial Adhesion , Capillaries/microbiology , Capillaries/pathology , Cell Adhesion Molecules/metabolism , Colony Count, Microbial , E-Selectin/metabolism , Endothelium, Vascular/microbiology , Endothelium, Vascular/pathology , Female , Fimbriae, Bacterial/metabolism , Heterografts , Humans , Inflammation/pathology , Male , Meningococcal Infections/microbiology , Meningococcal Infections/pathology , Mice, SCID , Middle Aged , Neutrophil Infiltration , Phagocytosis , Time Factors , Up-Regulation , Young Adult
8.
Cancer Cell ; 36(6): 597-612.e8, 2019 12 09.
Article in English | MEDLINE | ID: mdl-31708437

ABSTRACT

Rhabdoid tumors (RTs) are genomically simple pediatric cancers driven by the biallelic inactivation of SMARCB1, leading to SWI/SNF chromatin remodeler complex deficiency. Comprehensive evaluation of the immune infiltrates of human and mice RTs, including immunohistochemistry, bulk RNA sequencing and DNA methylation profiling studies showed a high rate of tumors infiltrated by T and myeloid cells. Single-cell RNA (scRNA) and T cell receptor sequencing highlighted the heterogeneity of these cells and revealed therapeutically targetable exhausted effector and clonally expanded tissue resident memory CD8+ T subpopulations, likely representing tumor-specific cells. Checkpoint blockade therapy in an experimental RT model induced the regression of established tumors and durable immune responses. Finally, we show that one mechanism mediating RTs immunogenicity involves SMARCB1-dependent re-expression of endogenous retroviruses and interferon-signaling activation.


Subject(s)
Chromatin Assembly and Disassembly/immunology , Rhabdoid Tumor/genetics , Rhabdoid Tumor/immunology , T-Lymphocytes/immunology , Animals , Chromosomal Proteins, Non-Histone/genetics , Chromosomal Proteins, Non-Histone/immunology , DNA-Binding Proteins/genetics , DNA-Binding Proteins/immunology , Humans , Immunohistochemistry/methods , Mice, Inbred C57BL , Mice, Transgenic , Mutation/genetics , Nuclear Proteins/genetics , Transcription Factors/genetics , Transcription Factors/immunology
9.
Nat Commun ; 9(1): 4450, 2018 10 25.
Article in English | MEDLINE | ID: mdl-30361638

ABSTRACT

The shape of cellular membranes is highly regulated by a set of conserved mechanisms that can be manipulated by bacterial pathogens to infect cells. Remodeling of the plasma membrane of endothelial cells by the bacterium Neisseria meningitidis is thought to be essential during the blood phase of meningococcal infection, but the underlying mechanisms are unclear. Here we show that plasma membrane remodeling occurs independently of F-actin, along meningococcal type IV pili fibers, by a physical mechanism that we term 'one-dimensional' membrane wetting. We provide a theoretical model that describes the physical basis of one-dimensional wetting and show that this mechanism occurs in model membranes interacting with nanofibers, and in human cells interacting with extracellular matrix meshworks. We propose one-dimensional wetting as a new general principle driving the interaction of cells with their environment at the nanoscale that is diverted by meningococci during infection.


Subject(s)
Bacterial Adhesion , Cell Membrane/metabolism , Nanofibers/chemistry , Animals , Cell Surface Extensions/metabolism , Cell Surface Extensions/ultrastructure , Human Umbilical Vein Endothelial Cells/metabolism , Human Umbilical Vein Endothelial Cells/ultrastructure , Humans , Liposomes , Mice, SCID , Models, Biological , Nanofibers/ultrastructure , Neisseria meningitidis/metabolism , Neisseria meningitidis/ultrastructure , Wettability
10.
Biomed Res Int ; 2015: 137893, 2015.
Article in English | MEDLINE | ID: mdl-26583087

ABSTRACT

Maintaining the identity of Foxp3(+) regulatory T cells (Tregs) is critical for controlling immune responses in the gut, where an imbalance between Tregs and T effector cells has been linked to inflammatory bowel disease. Accumulating evidence suggests that Tregs can convert into Th17 cells and acquire an inflammatory phenotype. In this study, we used an adoptive transfer model of Ag-specific T cells to study the contribution of different factors to the reprogramming of in vitro-generated Treg cells (iTreg) into IL-17-producing cells in a mouse model of gut inflammation in vivo. Our results show that intestinal inflammation induces the reprogramming of iTreg cells into IL-17-producing cells and that vitamin A restrains reprogramming in the gut. We also demonstrate that the presence of IL-2 during the in vitro generation of iTreg cells confers resistance to Th17 conversion but that IL-2 and retinoic acid (RA) cooperate to maintain Foxp3 expression following stimulation under Th17-polarizing conditions. Additionally, although IL-2 and RA differentially regulate the expression of different Treg cell suppressive markers, Treg cells generated under different polarizing conditions present similar suppressive capacity.


Subject(s)
Inflammation/genetics , Interleukin-17/biosynthesis , T-Lymphocytes, Regulatory/immunology , Th17 Cells/immunology , Vitamin A/administration & dosage , Animals , Cell Lineage/drug effects , Cell Lineage/immunology , Cellular Reprogramming/genetics , Cellular Reprogramming/immunology , Forkhead Transcription Factors/biosynthesis , Forkhead Transcription Factors/genetics , Gene Expression Regulation, Developmental , Humans , Immunity, Cellular/genetics , Inflammation/immunology , Interleukin-17/immunology , Interleukin-2/immunology , Intestinal Mucosa/metabolism , Intestines/pathology , Mice , T-Lymphocytes, Regulatory/drug effects , Th17 Cells/pathology , Tretinoin/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL